Overlooked brain cells may unlock the mystery of Alzheimer's

Overlooked brain cells may unlock the mystery of Alzheimer's

Is Alzheimer's Not a "Growing Disease" but a "Disease That Can't Be Discarded"?

When it comes to Alzheimer's disease, many people have the image of it being a "disease where harmful proteins accumulate in the brain." Indeed, the accumulation of abnormal tau proteins in the brain is one of the core pathologies when considering the progression of the disease. However, the research highlighted by the German newspaper WELT poses a slightly different question. The issue is not only "why does it increase?" but also "why can't it be expelled?"


The research was conducted by a team from the French National Institute of Health and Medical Research (Inserm) and Lille University Hospital. They focused on a little-known brain cell called tanycytes. Tanycytes are located around the third ventricle of the brain and have been studied as cells that mediate the exchange of information and substances between the blood system and cerebrospinal fluid. This research suggested that these cells might play the role of a "bridge" that receives tau proteins from the cerebrospinal fluid and transports them to the capillary side.


In the experiments, the movement path of tau proteins, which can be tracked with fluorescence, was first examined. It was found that tau was taken up by tanycytes in the cerebrospinal fluid and transported to the vascular side through their projections. Furthermore, when this transport was disrupted using genetic methods, tau could not effectively move from the cerebrospinal fluid to the blood. The research team indicated that, at least in animal models, tanycytes are one of the main routes for tau removal.


What is important here is that this is not just a "discovery of a pathway." The reason for the increase in tau can now be understood not only as abnormal production or aggregation within nerve cells but also from the perspective of a malfunction in the mechanism that expels it from the brain. An article in Nature also summarized this research by stating, "When tanycytes stop functioning, pathological tau accumulates in the brain." In other words, Alzheimer's is being reconsidered not only as a disease where toxic substances increase but also as a disease where the brain's "cleanup" fails.


The research team is also examining samples derived from Alzheimer's patients. In these samples, the structure of tanycytes was fragmented, and the pathway that should connect the cerebrospinal fluid and blood appeared damaged. Additionally, results suggesting that the tau ratio between blood and cerebrospinal fluid was low in patients, indicating that tau was not effectively moving to the blood side, were obtained. Moreover, according to Inserm's explanation, these changes were not observed in other dementias, suggesting that this phenomenon might be relatively specific to Alzheimer's disease.


The reason this discovery is said to "fundamentally change perspectives" lies here. Alzheimer's research has long focused primarily on nerve cells themselves or on the accumulating proteins amyloid-beta and tau. However, this research suggested that inconspicuous supporting cells and abnormalities in the boundary areas connecting the brain and the whole body might be deeply involved in the progression of the disease. The novel aspect is that it sheds light not only on the main actors of the disease but also on the dysfunction of the "behind-the-scenes" systems that maintain the brain environment.


Of course, it's too early to definitively say that a "new treatment method has been found" here. In the research introduction distributed by EurekAlert, the research team themselves explained that verification in larger groups and longitudinal data to determine whether tanycyte dysfunction is a cause or a result are needed. News-Medical also organized that while maintaining the health of tanycytes could become a future strategy, at this stage, it should be regarded as a research result that advances the understanding of the pathology.


How Was It Received on Social Media?

 

Observing how this research spread on social media, the prominent narrative is the "brain cleaning system." Nature's official X introduced it as "when special cells stop, disease-causing tau accumulates in the brain," and Medical Xpress summarized it as "tanycytes transport toxic tau from cerebrospinal fluid to blood." Specialist news accounts and scientific media spread the complex research using accessible and impactful terms like "hidden brain cells" and "brain-clearing cells."


On the other hand, LinkedIn posts by researchers and bio-media show a more in-depth reception. A post by Lille Neuroendocrinology included comments to the effect that it is an "important piece linking metabolic regulation and neurodegeneration," and posts by GEN and individual researchers expressed expectations such as "protecting tanycyte function could become a new therapeutic target." In the expert community on social media, the focus was more on the evaluation that "the understanding of the pathology has deepened," rather than a sensational "decisive treatment."


However, it seems that rather than a widespread discussion among the general public, it is mainly those with a high interest in scientific news who are reacting at this point. In fact, a related thread on Reddit sharing the Nature article displayed "no comments yet" at the time of retrieval. In other words, while it is a topic of interest, it is natural to see it as a stage where attention is first gathering from the periphery of research, medical, and science communication, rather than a large-scale public debate.


This temperature aligns well with the content of the research. On social media, strong headlines like "New Cause of Alzheimer's Discovered" or "Brain Drainage System Elucidated" tend to precede. However, a careful reading of the original paper and commentary reveals that what was demonstrated this time is an important result that "added another layer to the explanation of Alzheimer's," and not a complete form that directly leads to treatment. Nevertheless, its value is significant because it allows us to reconsider the disease not just as the accumulation of proteins itself, but as the breakdown of the biological system that should prevent accumulation.


Research on Alzheimer's disease has long pursued "what destroys the brain." This research strongly inserted the question, "How does the brain naturally protect itself?" If the decline in tanycyte function is part of the progression of the pathology, future strategies might expand not only to "attack the bad" but also to "maintain the state where it can be expelled." This is what it means for perspectives on Alzheimer's to change.


Source URL

Related Articles